Enzyme-responsive multistage vector for drug delivery to tumor tissue-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enzyme-responsive multistage vector for drug delivery to tumor tissue

Published:2016-11 Issue: Volume:113 Page:92-99
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Mi Yu,Wolfram Joy,Mu Chaofeng,Liu Xuewu,Blanco Elvin,Shen Haifa,Ferrari Mauro

Funder

Houston Methodist Research Institute

Ernest Cockrell Jr. Distinguished Endowed Chair (M.F.)

US Department of Defense

National Institute of Health

Department of Defense

State of Texas CPRIT

Publisher

Elsevier BV

Subject

Pharmacology

Reference52 articles.

1. Cancer nanotechnology: opportunities and challenges;Ferrari;Nat. Rev. Cancer,2005

2. Nanocarriers as an emerging platform for cancer therapy;Peer;Nat. Nanotechnol.,2007

3. Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases;Feng;Chem. Eng. Sci.,2003

4. Seven challenges for nanomedicine;Sanhai;Nat. Nanotechnol.,2008

5. Safety of nanoparticles in medicine;Wolfram;Curr. Drug Targets,2015

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Charge-Reversal Nano-Drug Delivery Systems in the Tumor Microenvironment: Mechanisms, Challenges, and Therapeutic Applications;International Journal of Molecular Sciences;2024-09-10

2. Revolutionizing Lung Cancer Treatment: Nanotechnology-Driven Advances in Targeted Drug Delivery and Novel Therapeutic Strategies;Journal of Drug Delivery Science and Technology;2024-09

3. A matrix metalloproteinase-responsive hydrogel system controls angiogenic peptide release for repair of cerebral ischemia/reperfusion injury;Neural Regeneration Research;2024-04-03

4. A review of matrix metalloproteinase-2-sensitive nanoparticles as a novel drug delivery for tumor therapy;International Journal of Biological Macromolecules;2024-03

5. Nanotechnology-based Approaches for Breast Cancer;Current Cancer Therapy Reviews;2024-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3